Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze DRUG stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DRUG investment potential.

What is DRUG stock price today?

Get real-time DRUG stock price, historical data, and price charts on Financhill. Track DRUG performance with our advanced analysis tools.

Is DRUG a good investment?

Evaluate DRUG investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy DRUG stock?

To buy DRUG stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DRUG?

View detailed market capitalization data and company valuation metrics for DRUG on our comprehensive analysis page.

What is the P/E ratio of DRUG?

Use our fundamental analysis tools to view DRUG P/E ratio and compare valuation metrics with industry peers.

What are DRUG earnings?

View DRUG earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Bright Minds Biosciences, Inc. 10K Form

Buy

DRUG
Bright Minds Biosciences, Inc.

Last Price:

$80.00

Seasonality Move:

-24.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DRUG News And Ratings

See the #1 stock for the next 7 days that we like better than DRUG

DRUG Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-2.6M
Price / Cash Flow:	0
Annual Sales:	$5.36
Price / Book:	15.02

Profitability

EPS (TTM):	-0.94480
Net Income (TTM):	$-6.4M
Gross Margin:	$-53.9K
Return on Equity:	-25.41%
Return on Assets:	-25.02%

Bright Minds Biosciences, Inc. Earnings Forecast

Key Bright Minds Biosciences, Inc. Financial Ratios

Per Share Earnings over the last 6 years have been positive in 2 years.

Bright Minds Biosciences, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	DRUG
Website:	brightmindsbio.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	86.56
Quick Ratio:	84.94

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

DRUG Technical Analysis vs Fundamental Analysis

Buy

Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy or a Sell?

Bright Minds Biosciences, Inc. stock is rated a Buy

The current Bright Minds Biosciences, Inc. [DRUG] share price is $80.50. The Score for DRUG is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.